Paris
France
34
2014-01-30
26
2015-02-24
These are the the leading inventors for applications assigned to AVENTIS PHARMA S.A.:
AVENTIS PHARMA S.A. based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
MODIFIED SOLUBLE FGF RECEPTOR FC FUSIONS METHOD
#2 | 2013-12-26 β Patent 8,962,021 granted on 2015-02-24Solid pharmaceutical composition comprising telithromycin
#3 | 2013-04-25SEMULOPARIN FOR THE PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT UNDERGOING MAJOR ORTHOPEDIC SURGERY
#4 | 2012-11-01 β Patent 8,685,705 granted on 2014-04-01Desmosterol-producing yeast strains and uses thereof
#5 | 2012-08-02 β Patent 8,481,487 granted on 2013-07-09Modified soluble FGF receptor Fc fusions method
#6 | 2009-05-26 β Patent 7,537,887 granted on 2009-05-26Net, a transcription factor of the TCF family, as regulator of angiogenic factor expression
#7 | 2009-01-22 β Patent 7,687,274 granted on 2010-03-30Method for determining specific groups constituting heparins or low molecular weight heparins
#8 | 2008-10-23 β Patent 7,629,374 granted on 2009-12-08Use of aminoindazole derivatives for the inhibition of tau phosphorylation
#9 | 2008-08-14Galenic Applications of Self-Emulsifying Mixtures of Lipidic Excipients
#10 | 2008-08-07 β Patent 8,608,961 granted on 2013-12-17Method for affinity chromatography of antithrombin III
#11 | 2008-08-07 β Patent 7,604,970 granted on 2009-10-20Variants of the PapM polypeptide of bacteria of the genus
#12 | 2008-05-08USE OF A VECTOR COMPRISING A NUCLEIC ACID ENCODING AN ANTI-ANGIOGENIC FACTOR FOR THE TREATMENT OF CORNEAL NEOVASCULARIZATION
#13 | 2008-03-20 β Patent 8,709,426 granted on 2014-04-29Nucleotide sequence coding for variable regions of Ξ² chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
#14 | 2008-03-06COMBINATION OF A CB1 RECEPTOR ANTAGONIST AND OF SIBUTRAMINE, THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE TREATMENT OF OBESITY
#15 | 2008-02-07 β Patent 8,431,119 granted on 2013-04-30Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases
#16 | 2007-09-13 β Patent 7,678,766 granted on 2010-03-16Process for the preparation of cyclosporin derivatives
#17 | 2007-08-23COMBINATION OF A CB1 RECEPTOR ANTAGONIST AND OF A PRODUCT WHICH ACTIVATES DOPAMINERGIC NEUROTRANSMISSION IN THE BRAIN, THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE TREATMENT OF PARKINSON'S DISEASE
#18 | 2007-07-05 β Patent 7,407,981 granted on 2008-08-05Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
#19 | 2007-05-15 β Patent 7,217,705 granted on 2007-05-15Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease
#20 | 2007-05-01 β Patent 7,211,399 granted on 2007-05-01Method for detecting leptin receptor ligands
#21 | 2007-04-26 β Patent 7,582,669 granted on 2009-09-01Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
#22 | 2007-01-23 β Patent 7,166,629 granted on 2007-01-23Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
#23 | 2006-11-16COMBINATION OF A CB1 RECEPTOR ANTAGONIST AND OF SIBUTRAMINE, THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE TREATMENT OF OBESITY
#24 | 2006-11-07 β Patent 7,132,414 granted on 2006-11-07Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
#25 | 2006-07-27Pharmaceutical compositions based on azetidine derivatives
#26 | 2006-07-11 β Patent 7,074,821 granted on 2006-07-11Taxoids, their preparation and pharmaceutical composition containing them
#27 | 2006-04-06 β Patent 7,196,109 granted on 2007-03-27Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
#28 | 2006-01-26 β Patent 7,241,601 granted on 2007-07-10Process for the preparation of Fexofenadine
#29 | 2005-12-29 β Patent 7,227,022 granted on 2007-06-05Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
#30 | 2005-09-29 β Patent 7,279,480 granted on 2007-10-09Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
#31 | 2005-07-28 β Patent 7,179,909 granted on 2007-02-20Process for the manufacture of a product of the thiazolo [3,4,5-de] [4,1]benzothiazepine type
#32 | 2005-02-10 β Patent 7,148,258 granted on 2006-12-12Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
#33 | 2005-02-10 β Patent 7,037,944 granted on 2006-05-02Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
#34 | 2005-02-03 β Patent 7,470,781 granted on 2008-12-30Formulation of stabilized cationic transfection agent(s)/nucleic acid particles
19682 β